TheEdgeResearch
Home / Stocks / DOSEF

Doseology Sciences Inc. (DOSEF)

OTC Healthcare Medical - Pharmaceuticals
$0.10 ▲ +0.00%
Market Cap
$433,355
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
2.29
52-Wk Range
0.0071-1
CEO
Kareem Baalbaki
Country
CA
Currency
USD

Doseology Sciences Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Kelowna, BC, CA. The stock last traded at $0.10, up 0.00% on the session, giving a market capitalisation of $433,355. On trailing twelve-month figures it carries a trailing P/E of -0.40, a net margin of -1618.1%. Its beta of 2.29 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.40
Price / Sales
5.96
Price / Book
5.20
EV / EBITDA
-0.28
Gross margin
-628.7%
Operating margin
-1498.1%
Net margin
-1618.1%
Return on equity
—
Debt / equity
0.00
Current ratio
1.80
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
3
IPO date
2022-05-11
Headquarters
Kelowna, BC, CA
About Doseology Sciences Inc.

Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in January 2020. Doseology Sciences Inc. was incorporated in 2019 and is based in Kelowna, Canada.

Comparable companies

Doseology Sciences Inc. is most often compared with the following Healthcare names:

CLABFCPIVFENSCENZNFAMDFFNAMFZMDKNBIFMYNDFSRNE
More research on DOSEF
DOSEF technical analysis DOSEF TheEdge Score Compare against peers
Open full interactive analysis & DCF →